Case Reports
doi: 10.1097/00002508-200409000-00016.
Multiple sclerosis with severe pain and allodynia alleviated by oral ketamine
Affiliations
- PMID: 15322448
- DOI: 10.1097/00002508-200409000-00016
Item in Clipboard
Case Reports
Multiple sclerosis with severe pain and allodynia alleviated by oral ketamine
Clin J Pain.
2004 Sep-Oct.
Abstract
The objective of this study is to determine the effect of oral ketamine on pain and allodynia associated with multiple sclerosis. A 60-year-old woman with multiple sclerosis was referred to our clinic because of severe pain and allodynia. Oral ketamine was started at a dose of 20 mg once a day and increased to twice a day. Oral ketamine was effective in the treatment of the pain and allodynia associated with multiple sclerosis.
Similar articles
-
Treatment of central post-stroke pain with oral ketamine.Pain. 2001 May;92(1-2):311-3. doi: 10.1016/s0304-3959(00)00488-7. Pain. 2001. PMID: 11323153
-
Bilateral central pain sensitization in rats following a unilateral thalamic lesion may be treated with high doses of ketamine.BMC Vet Res. 2013 Mar 27;9:59. doi: 10.1186/1746-6148-9-59. BMC Vet Res. 2013. PMID: 23537119 Free PMC article.
-
Concentration-effect relationship of intravenous alfentanil and ketamine on peripheral neurosensory thresholds, allodynia and hyperalgesia of neuropathic pain.Pain. 2001 Mar;91(1-2):177-87. doi: 10.1016/s0304-3959(00)00433-4. Pain. 2001. PMID: 11240090 Clinical Trial.
-
The role of ketamine in pain management.Biomed Pharmacother. 2006 Aug;60(7):341-8. doi: 10.1016/j.biopha.2006.06.021. Epub 2006 Jul 5. Biomed Pharmacother. 2006. PMID: 16854557 Review.
-
Parenteral ketamine as an analgesic adjuvant for severe pain: development and retrospective audit of a protocol for a palliative care unit.J Palliat Med. 2005 Feb;8(1):49-57. doi: 10.1089/jpm.2005.8.49. J Palliat Med. 2005. PMID: 15662173 Review.
Cited by
-
The Compelling Role of Brain-Derived Neurotrophic Factor Signaling in Multiple Sclerosis: Role of BDNF Activators.CNS Neurosci Ther. 2024 Dec;30(12):e70167. doi: 10.1111/cns.70167. CNS Neurosci Ther. 2024. PMID: 39654365 Free PMC article. Review.
-
Neuropathic pain in animal models of nervous system autoimmune diseases.Mediators Inflamm. 2013;2013:298326. doi: 10.1155/2013/298326. Epub 2013 May 8. Mediators Inflamm. 2013. PMID: 23737643 Free PMC article.
-
Low-dose ketamine provides poor analgesia for pain in redback spider envenoming.Br J Clin Pharmacol. 2019 Oct;85(10):2423-2427. doi: 10.1111/bcp.14052. Epub 2019 Aug 6. Br J Clin Pharmacol. 2019. PMID: 31269538 Free PMC article.
-
Targeting Sigma Receptors for the Treatment of Neurodegenerative and Neurodevelopmental Disorders.CNS Drugs. 2023 May;37(5):399-440. doi: 10.1007/s40263-023-01007-6. Epub 2023 May 11. CNS Drugs. 2023. PMID: 37166702 Free PMC article. Review.
-
Oral ketamine in the palliative care setting: a review of the literature and case report of a patient with neurofibromatosis type 1 and glomus tumor-associated complex regional pain syndrome.Am J Hosp Palliat Care. 2012 Jun;29(4):308-17. doi: 10.1177/1049909111416345. Epub 2011 Jul 29. Am J Hosp Palliat Care. 2012. PMID: 21803784 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
